Mei Wang
biotech focusing on world leading r&d to solve unmet medical needs
dizal pharmaceutical
team leaderYuhuan Wang
iX Biopharma is established in 2008, and listed on Singapore Stock Exchange (Catalist Board) in 2015. iX is a specialist in novel wafer formulations using patented sublingual delivery technology, WaferiXTM , which is patented in China to 2033. R&D and manufacturing at wholly-owned GMP licensed facility in Melbourne, Australia.
iX Biopharma Ltd
Senior BD Managergrace wang
DENTAL MATERIALS
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.

English (UK)
中文版
Responsive Web Design powered by